drugset / Trial / NCT01643252

Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery

NCT01643252

Phase 3 Withdrawn Glaukos Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

The objectives of this study are to evaluate the safety and efficacy of corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System as compared to placebo in impeding the progression of, and/or reducing, maximum corneal curvature.

Timeline

Start
2012-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Riboflavin Other / unclassified 0.12 % Topical

Indications